Image pharmaphorum Editor R&D 2021: the year mRNA therapeutics came of age It started with two Covid-19 vaccines – 2021 is the year interest in mRNA therapeutics boomed, reports Katrina Megget Patients From patient engagement to patient centricity Words matter. In the pharma industry, “patient engagement” and “patient centricity” might seem like interchangeable bits of corporate jargon. Digital Digital health innovation in 2022: Anticipating healthcare t... We spoke with Tanja Dowe, ahead of the annual J.P. Sales & Marketing Seizing opportunities with perfectly pitched messages Personal relationships have been the dominant force in sales for generations but the pandemic has ripped up this conveyer belt of convenience. Load more results
R&D 2021: the year mRNA therapeutics came of age It started with two Covid-19 vaccines – 2021 is the year interest in mRNA therapeutics boomed, reports Katrina Megget
Patients From patient engagement to patient centricity Words matter. In the pharma industry, “patient engagement” and “patient centricity” might seem like interchangeable bits of corporate jargon.
Digital Digital health innovation in 2022: Anticipating healthcare t... We spoke with Tanja Dowe, ahead of the annual J.P.
Sales & Marketing Seizing opportunities with perfectly pitched messages Personal relationships have been the dominant force in sales for generations but the pandemic has ripped up this conveyer belt of convenience.
News US pharma tariffs of up to 100% finalised by Trump Trump signs his pharma tariffs executive order, which won't affect most large pharma groups but could deal a hefty blow to smaller companies.
Sales & Marketing Sponsored Using AI-driven synthetic personas to take your insights fur... As AI continues to reshape the healthcare landscape, pharma teams are beginning to leverage synthetic personas.
